Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 4
2010 3
2011 2
2012 2
2013 3
2014 2
2015 5
2016 3
2017 4
2018 3
2019 4
2020 7
2021 13
2022 14
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. Among authors: lanthier n. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. Méndez-Sánchez N, et al. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248211 Free article. No abstract available.
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova-Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Romero-Gómez M, Huot-Marchand P, Baudin M, Richard MP, Abitbol JL, Broqua P, Junien JL, Abdelmalek MF; NATIVE Study Group. Francque SM, et al. Among authors: lanthier n. N Engl J Med. 2021 Oct 21;385(17):1547-1558. doi: 10.1056/NEJMoa2036205. N Engl J Med. 2021. PMID: 34670042 Clinical Trial.
Cell transplantation-based regenerative medicine in liver diseases.
Cardinale V, Lanthier N, Baptista PM, Carpino G, Carnevale G, Orlando G, Angelico R, Manzia TM, Schuppan D, Pinzani M, Alvaro D, Ciccocioppo R, Uygun BE. Cardinale V, et al. Among authors: lanthier n. Stem Cell Reports. 2023 Aug 8;18(8):1555-1572. doi: 10.1016/j.stemcr.2023.06.005. Stem Cell Reports. 2023. PMID: 37557073 Free PMC article. Review.
Adipose tissues as endocrine target organs.
Lanthier N, Leclercq IA. Lanthier N, et al. Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):545-58. doi: 10.1016/j.bpg.2014.07.002. Epub 2014 Jul 11. Best Pract Res Clin Gastroenterol. 2014. PMID: 25194174 Review.
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease.
Ventura-Cots M, Argemi J, Jones PD, Lackner C, El Hag M, Abraldes JG, Alvarado E, Clemente A, Ravi S, Alves A, Alboraie M, Altamirano J, Barace S, Bosques F, Brown R, Caballeria J, Cabezas J, Carvalhana S, Cortez-Pinto H, Costa A, Degré D, Fernandez-Carrillo C, Ganne-Carrie N, Garcia-Tsao G, Genesca J, Koskinas J, Lanthier N, Louvet A, Lozano JJ, Lucey MR, Masson S, Mathurin P, Mendez-Sanchez N, Miquel R, Moreno C, Mounajjed T, Odena G, Kim W, Sancho-Bru P, Warren Sands R, Szafranska J, Verset L, Schnabl B, Sempoux C, Shah V, Shawcross DL, Stauber RE, Straub BK, Verna E, Tiniakos D, Trépo E, Vargas V, Villanueva C, Woosley JT, Ziol M, Mueller S, Stärkel P, Bataller R. Ventura-Cots M, et al. Among authors: lanthier n. Gut. 2022 Sep;71(9):1856-1866. doi: 10.1136/gutjnl-2021-324295. Epub 2022 Jan 6. Gut. 2022. PMID: 34992134 Free PMC article.
Granuloma formation within perihepatic lymphadenopathy.
Vande Berg P, Borbath I, Baldin P, Vande Berg D, Hainaut P, Lanthier N. Vande Berg P, et al. Among authors: lanthier n. Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101504. doi: 10.1016/j.clinre.2020.07.009. Epub 2020 Sep 2. Clin Res Hepatol Gastroenterol. 2021. PMID: 32888874 No abstract available.
Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia.
Dolly A, Pötgens SA, Thibaut MM, Neyrinck AM, de Castro GS, Galbert C, Lefevre C, Wyart E, Gomes SP, Gonçalves DC, Lanthier N, Baldin P, Huot JR, Bonetto A, Seelaender M, Delzenne NM, Sokol H, Bindels LB. Dolly A, et al. Among authors: lanthier n. J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1569-1582. doi: 10.1002/jcsm.13246. Epub 2023 May 1. J Cachexia Sarcopenia Muscle. 2023. PMID: 37127348 Free PMC article.
Jaundice with severe leucocytosis.
Haxhe S, Baldin P, Trefois P, Havelange V, Lanthier N. Haxhe S, et al. Among authors: lanthier n. J Hepatol. 2024 Mar;80(3):e103-e105. doi: 10.1016/j.jhep.2023.10.014. J Hepatol. 2024. PMID: 38368018 No abstract available.
73 results